Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal
2 other identifiers
observational
718
1 country
1
Brief Summary
Under this study, patients who require removal of their third molars (wisdom teeth) will be diagnosed, evaluated and treated. In addition, tooth, bone and gum tissue samples will be collected for use in bone, wound healing, microbiology and genetic research. Patients 16-50 years of age who require wisdom tooth removal may be eligible for this study. Participants may have one or all of their wisdom teeth removed at one time. The surgery is done under local anesthetic. In addition, conscious sedation may be administered, if the patient wishes. Besides wisdom tooth removal, patients are asked to donate a small sample of jaw bone (from the lining of the inner wall of the tooth socket) and gum tissue (from the area of the surgical site). The samples are collected at the same time as the tooth extraction. The bone sample is about the size of a pencil point (1.5 millimeters wide and 3 millimeters long) and the gum tissue sample is 1 millimeter. Removal of these samples should not cause any additional discomfort or increase the time required for the surgery or for healing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2006
CompletedFirst Submitted
Initial submission to the registry
April 19, 2006
CompletedFirst Posted
Study publicly available on registry
April 20, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2013
CompletedOctober 6, 2017
January 28, 2013
April 19, 2006
October 5, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- \<TAB\>
- Males and females aged 18 to 50 years
- Evidence of need for third molar extraction as determined by medical and dental history, as well as clinical and radiographic evaluation
- Willing to provide at least one wisdom tooth for research purposes
- Willing to provide one or more of the following tissue types for research purposes:
- Excessive gingival tissue around extraction sockets
- Oral tissues from the floor of the mouth, cheek, palate and/or lateral border of the tongue
- Small biopsies of alveolar bone from the sockets that surround the wisdom teeth
- America Society of Anesthesiologists (ASA) status I or II
You may not qualify if:
- Pregnant or nursing
- Clinical signs of infection and/or inflammation, or acute pain at any extraction site at the time of the screening evaluation
- Known bleeding disorders or conditions associated with bleeding, including Hemophilia, von Willebrand disease, protein C/S deficiency, antithrombin III deficiency, and liver disease.
- Currently using anticoagulation (blood thinning) medications, including but not limited to warfarin (Coumadin), ticlopidine (Ticlid) and clopidogril (Plavix). Subjects who are currently taking Aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) may be eligible for enrollment.
- Known or suspected allergy or adverse reaction to any of the agents used for local anesthesia, suture material, or conscious sedation medications
- Surgical removal of the wisdom teeth is expected to be unusually difficult based on panoramic radiograph. Indicators of unusual difficulty include increased depth of tooth impaction, extreme angulation of a tooth, and close proximity of a tooth to the inferior alveolar nerve canal and/or maxillary sinus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Foster JS, Palmer RJ Jr, Kolenbrander PE. Human oral cavity as a model for the study of genome-genome interactions. Biol Bull. 2003 Apr;204(2):200-4. doi: 10.2307/1543559.
PMID: 12700154BACKGROUNDPalmer RJ Jr, Gordon SM, Cisar JO, Kolenbrander PE. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J Bacteriol. 2003 Jun;185(11):3400-9. doi: 10.1128/JB.185.11.3400-3409.2003.
PMID: 12754239BACKGROUNDKolenbrander PE, Egland PG, Diaz PI, Palmer RJ Jr. Genome-genome interactions: bacterial communities in initial dental plaque. Trends Microbiol. 2005 Jan;13(1):11-5. doi: 10.1016/j.tim.2004.11.005.
PMID: 15639626BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Carol W Bassim, D.M.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 19, 2006
First Posted
April 20, 2006
Study Start
April 14, 2006
Study Completion
January 28, 2013
Last Updated
October 6, 2017
Record last verified: 2013-01-28